These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants. Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425 [TBL] [Abstract][Full Text] [Related]
4. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein. Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955 [TBL] [Abstract][Full Text] [Related]
6. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720 [TBL] [Abstract][Full Text] [Related]
8. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design. Ma C; Wang L; Tao X; Zhang N; Yang Y; Tseng CK; Li F; Zhou Y; Jiang S; Du L Vaccine; 2014 Oct; 32(46):6170-6176. PubMed ID: 25240756 [TBL] [Abstract][Full Text] [Related]
9. Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen. Ahuja R; Vishwakarma P; Raj S; Kumar V; Khatri R; Lohiya B; Saxena S; Kaur G; Singh G; Asthana S; Ahmed S; Samal S Hum Vaccin Immunother; 2024 Dec; 20(1):2351664. PubMed ID: 38757508 [TBL] [Abstract][Full Text] [Related]
10. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228 [TBL] [Abstract][Full Text] [Related]
11. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752 [TBL] [Abstract][Full Text] [Related]
12. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein. Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice. Kim E; Okada K; Kenniston T; Raj VS; AlHajri MM; Farag EA; AlHajri F; Osterhaus AD; Haagmans BL; Gambotto A Vaccine; 2014 Oct; 32(45):5975-82. PubMed ID: 25192975 [TBL] [Abstract][Full Text] [Related]
14. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723 [TBL] [Abstract][Full Text] [Related]
15. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. Song F; Fux R; Provacia LB; Volz A; Eickmann M; Becker S; Osterhaus AD; Haagmans BL; Sutter G J Virol; 2013 Nov; 87(21):11950-4. PubMed ID: 23986586 [TBL] [Abstract][Full Text] [Related]
16. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection. Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B mBio; 2020 Apr; 11(2):. PubMed ID: 32265331 [TBL] [Abstract][Full Text] [Related]
17. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model. Bodmer BS; Fiedler AH; Hanauer JRH; Prüfer S; Mühlebach MD Virology; 2018 Aug; 521():99-107. PubMed ID: 29902727 [TBL] [Abstract][Full Text] [Related]
18. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus. Kim MH; Kim HJ; Chang J PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652 [TBL] [Abstract][Full Text] [Related]
19. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model. Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758 [TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]